Down-regulation of RB1 and TP53 as potential predicting biomarkers for castration-resistant prostate cancer (CRPC): Indonesian retrospective cohort study

INTRODUCTION: Androgen deprivation therapy (ADT) has remained the first line strategy for treatment of advanced prostate cancers. Despite the profound efficacy of ADT in preventing clinical remission, 30–50% of advanced prostate cancer will develop resistance to hormonal deprivation therapy. This st...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Med Surg (Lond)
Autors principals: Soerohardjo, Indrawarman, Widodo, Irianiwati, Heriyanto, Didik Setyo, Zulfiqqar, Andy, Anwar, Sumadi Lukman
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Cohort Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7704423/
https://ncbi.nlm.nih.gov/pubmed/33299560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amsu.2020.11.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars